Skip to content
Quebec News Tribune – Lifestyle
Author:
Asher Biotherapeutics, Inc.
Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline
May 21, 2026